Literature DB >> 20047848

Evolution of methicillin-resistant Staphylococcus aureus clones in Latin America.

Eduardo Rodríguez-Noriega1, Carlos Seas, Manuel Guzmán-Blanco, Carlos Mejía, Carlos Alvarez, Luis Bavestrello, Jeannete Zurita, Jaime Labarca, Carlos M Luna, Mauro J C Salles, Eduardo Gotuzzo.   

Abstract

OBJECTIVES: Methicillin-resistant Staphylococcus aureus (MRSA) is a prominent nosocomial bacterial pathogen, associated with significant morbidity and mortality. The global incidence is increasing, and Latin America is no exception. This article reviews MRSA clonal distribution in Latin America and implications for clinical practice.
DESIGN: A PubMed literature search (1966-2008) identified 32 articles that characterized MRSA clones in Latin America.
RESULTS: Data from these articles show that since 1990, several epidemic MRSA clones have spread in Latin America. The multidrug-resistant Brazilian clone is widespread, especially in Brazil and Argentina, but more recently clones with susceptibility to a range of antibiotics have been detected in Brazil, whereas in Argentina, as in Chile, Colombia and Paraguay, the multidrug-resistant Cordobes/Chilean clone prevails. In Mexico, the New York/Japan clone is most frequent. Data were not available from every country and, despite the increasing prevalence of community MRSA infections, most were collected from tertiary care centers.
CONCLUSIONS: A variety of epidemic MRSA clones are circulating in Latin America, some of which harbor genes that encode multidrug resistance or enhanced pathogenicity. Continued collection and reporting of epidemiological data is crucial for effective prevention and treatment. Copyright 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20047848     DOI: 10.1016/j.ijid.2009.08.018

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  33 in total

1.  Molecular epidemiology and characterisation of MRSA isolates from Trinidad and Tobago.

Authors:  S Monecke; H Nitschke; P Slickers; R Ehricht; W Swanston; M Manjunath; R Roberts; P E Akpaka
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-09       Impact factor: 3.267

2.  Dry collection and culture methods for recovery of methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains from indoor home environments.

Authors:  Meghan F Davis; Patrick Baron; Lance B Price; D'Ann L Williams; Selvi Jeyaseelan; Ian R Hambleton; Gregory B Diette; Patrick N Breysse; Meredith C McCormack
Journal:  Appl Environ Microbiol       Date:  2012-01-27       Impact factor: 4.792

3.  Characterization of methicillin-resistant Staphylococcus aureus strains recovered from a phase IV clinical trial for linezolid versus vancomycin for treatment of nosocomial pneumonia.

Authors:  Rodrigo E Mendes; Lalitagauri M Deshpande; Davida S Smyth; Bo Shopsin; David J Farrell; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2012-09-12       Impact factor: 5.948

Review 4.  Integrated Multilevel Surveillance of the World's Infecting Microbes and Their Resistance to Antimicrobial Agents.

Authors:  Thomas F O'Brien; John Stelling
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

5.  Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Costa Rican children.

Authors:  Natalia Jimenez-Truque; Elizabeth J Saye; Isaac Thomsen; Marco Luis Herrera; C Buddy Creech
Journal:  Pediatr Infect Dis J       Date:  2014-07       Impact factor: 2.129

6.  Frequent occurrence of trimethoprim-sulfamethoxazole hetero-resistant Staphylococcus aureus isolates in different African countries.

Authors:  C Coelho; H de Lencastre; M Aires-de-Sousa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-03       Impact factor: 3.267

7.  Activity of Debio1452, a FabI inhibitor with potent activity against Staphylococcus aureus and coagulase-negative Staphylococcus spp., including multidrug-resistant strains.

Authors:  Robert K Flamm; Paul R Rhomberg; Nachum Kaplan; Ronald N Jones; David J Farrell
Journal:  Antimicrob Agents Chemother       Date:  2015-02-17       Impact factor: 5.191

8.  Molecular epidemiology of hospital-onset methicillin-resistant Staphylococcus aureus infections in Southern Chile.

Authors:  G Medina; A L Egea; C Otth; L Otth; H Fernández; J L Bocco; M Wilson; C Sola
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-06-14       Impact factor: 3.267

9.  Transferable vancomycin resistance in a community-associated MRSA lineage.

Authors:  Flávia Rossi; Lorena Diaz; Aye Wollam; Diana Panesso; Yanjiao Zhou; Sandra Rincon; Apurva Narechania; Galen Xing; Thais S R Di Gioia; André Doi; Truc T Tran; Jinnethe Reyes; Jose M Munita; Lina P Carvajal; Alejandra Hernandez-Roldan; Denise Brandão; Inneke Marie van der Heijden; Barbara E Murray; Paul J Planet; George M Weinstock; Cesar A Arias
Journal:  N Engl J Med       Date:  2014-04-17       Impact factor: 91.245

Review 10.  Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology.

Authors:  Sahreena Lakhundi; Kunyan Zhang
Journal:  Clin Microbiol Rev       Date:  2018-09-12       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.